PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Motif Bio | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.075p | +0.22% | 33.575p | 33.40p | 33.75p | 33.95p | 33.50p | 33.60p | 245,825 | 16:35:17 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 0.0 | -33.2 | -14.1 | - | 99.60 |
Motif Bio (MTFB) News Headlines
Motif Bio News
| Date | Time | Source | Headline |
|---|---|---|---|
| 17/8/2018 | 07:00 | RNSNON | Motif Bio PLC Iclaprim Data at ESCMID/ASM Conference |
| 14/8/2018 | 16:49 | UKREG | Motif Bio PLC Holding(s) in Company |
| 14/8/2018 | 16:48 | UKREG | Motif Bio PLC Holding(s) in Company |
| 14/8/2018 | 14:22 | ALNC |  Motif Bio Says US FDA Accepts Filing For Iclaprim Skin Infection Drug |
| 14/8/2018 | 07:47 | ALNCF | Alliance News Flash Headline |
| 14/8/2018 | 07:01 | UKREG | Motif Bio PLC FDA Acceptance of New Drug Application |
| 09/8/2018 | 07:01 | RNSNON | Motif Bio PLC Investor Events in August and September |
| 08/8/2018 | 12:28 | ALNC | Motif Bio Gets Patent Permission In US For Antibiotic Iclaprim |
| 08/8/2018 | 07:00 | UKREG | Motif Bio PLC Notice of Allowance for Two U.S. Iclaprim Patents |
| 02/8/2018 | 16:35 | UKREG | Motif Bio PLC Price Monitoring Extension |
1 Year Motif Bio Chart |
Intraday Motif Bio Chart |
